Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

7results about How to "Strong regenerative" patented technology

A core-shell magnetic molecular imprinted polymer material and its preparation method and application

The present invention relates to a core-shell magnetic molecular imprinted polymer material, a preparation method and its application in enriching 25 steroid hormones in blood. The present invention is based on the polymerization reaction of 3,3-dihydroxybenzidine and p-benzoquinone, precipitates and polymerizes on the surface of magnetic ferroferric oxide nanoparticles modified with silicon dioxide to form a polymer layer, and simultaneously uses virtual template betamethasone for imprinting treatment to obtain a core-shell magnetic molecular imprinted polymer material. The core-shell magnetic molecular imprinted polymer material prepared by the present invention has good magnetic responsiveness. The adsorption test of 25 steroid hormones shows that the core-shell magnetic molecular imprinted polymer material of the present invention has good adsorption and desorption effects, and is convenient to separate and recyclable after adsorption, and has good application prospects.
Owner:BEIJING UNIV OF CHEM TECH

Method for improving yield of endometrial stem cell exosome

The invention provides a co-culture system for increasing the yield of endometrial stem cell exosomes and a method for increasing the yield of endometrial stem cell exosomes, firstly, fibroblasts are subjected to mitomycin C pretreatment, so that the cells are stagnated in G1, S and G2 stages of a cell cycle, meanwhile, RNA and protein synthesis continues to be carried out, and the endometrial stem cell exosomes are obtained; the fibroblasts are kept in a non-proliferative but metabolic active state; then, endometrial stem cells extracted from endometrial tissues in the proliferation period and fibroblasts are indirectly co-cultured through a Transwell chamber and are separated through a semi-permeable membrane, and stem cell differentiation caused by inter-cell contact reaction and fusion of the stem cells and somatic cells is eliminated; after co-culture, taking out the endometrial stem cells, putting the endometrial stem cells into a serum-free culture medium special for exosomes for separate culture, harvesting cell supernate, and purifying the exosomes; compared with the endometrial stem cells which are independently cultured in the whole process, the co-culture system disclosed by the invention has the advantages that the amplification speed of the endometrial stem cells and the exosome yield of unit quantity of cells are remarkably improved.
Owner:SHENZHEN RUIPUXUN BIOPHARMACEUTICAL CO LTD

Organic nanocage adsorption material and preparation method thereof

The invention belongs to the technical field of sewage treatment, and particularly relates to an organic nanocage adsorption material and a preparation method thereof. According to the invention, an organic nanocage structure is introduced on the activated carbon through Friedel-Crafts alkylation reaction, so that the adsorption capacity and selectivity of the activated carbon can be effectively increased. The prepared adsorbing material has good regeneration capacity, namely, the adsorbing material can be regenerated through a simple physical or chemical method after adsorption saturation, so that the use cost is reduced, and secondary pollution is reduced.
Owner:HUADIAN FOSHAN ENERGY CO LTD

A network of porous poly(3,4-hydroxybutyrate) microspheres, its preparation method and application

This invention discloses a network-like porous poly(3,4-hydroxybutyrate) microsphere, its preparation method, and its applications, belonging to the field of biomedical materials technology. The microspheres exhibit a villous network structure with a continuous, irregular "ridge-valley" topology on their surface. The network-like porous poly(3,4-hydroxybutyrate) microspheres provided by this invention maintain good structural integrity even after 6 months of in vivo implantation, significantly increase ATP levels in fibroblasts under glucose-free conditions, and inhibit cell senescence. They also induce macrophages to transform from a pro-inflammatory M1 phenotype to a pro-repair M2 phenotype, avoiding the excessive inflammatory response commonly seen in PLLA-type microspheres, and demonstrate superior collagen regeneration promotion compared to PLLA-type microspheres. Furthermore, they facilitate cell adhesion and proliferation.
Owner:SICHUAN UNIV

Method of monitoring particulate filter regeneration in exhaust system of internal combustion engine

PendingCN119122653ARegeneration monitoringprevent incomplete regenerationGas treatmentDispersed particle filtrationExhaust fumesInternal combustion engine
The invention relates to a method for monitoring a particle filter (40) in an exhaust gas system (30) of an internal combustion engine (10). The method comprises the steps of: determining a loading of the particulate filter (40) by means of a pressure difference measurement between an inlet of the particulate filter (40) and an outlet of the particulate filter (40), modeling the loading of the particulate filter (40) by means of a soot loading model for the particulate filter (40), initiating regeneration of the particulate filter (40), the particulate removal from the particulate filter (40) determined by the differential pressure measurement is compared with the particulate removal modeled by the soot loading model, and an error report is output when the difference between the calculated particulate removal and the measured particulate removal exceeds a threshold. The invention also relates to an internal combustion engine (10) having a control unit (60) and an exhaust gas system (30) in order to carry out such a method.
Owner:VOLKSWAGEN AG

Recombinant expression plasmid, method for constructing recombinant humanized collagen escherichia coli, and preparation method and application of transdermal recombinant humanized collagen

The invention discloses a recombinant expression plasmid, a method for constructing recombinant humanized collagen Escherichia coli and a preparation method and application of transdermal recombinant humanized collagen, and belongs to the technical field of polypeptide and genetic engineering. The recombinant humanized collagen Escherichia coli is constructed, and under induction of an inducer, the transdermal recombinant humanized collagen Escherichia coli is obtained. The bidirectional promoter initiates the polynucleotide of the recombinant III type human collagen and the polynucleotide of the recombinant III type human collagen to be expressed and split at the same time; and producing the recombinant II-type human collagen and the recombinant III-type human collagen. The method has the beneficial effects that the interference of homodromous expression is avoided; the recombinant II-type human collagen and the recombinant III-type human collagen are produced, and the recombinant II-type human collagen and the recombinant III-type human collagen have a synergistic effect, so that the collagen regeneration capacity and the transdermal effect are more excellent.
Owner:SHANDONG YICAI HERUI BIOTECHNOLOGY CO LTD

A method for constructing and applying an enzyme-based model of coronary artery microcirculation injury in zebrafish.

PendingCN122074447AReduce non-specific damageThe damaged area is highly localizedIn-vivo testing preparationsAnimal husbandryCoenocyteBiology
This invention relates to the field of animal model construction technology, and more particularly to a method for constructing a zebrafish coronary artery microcirculation injury model based on enzyme stripping and its application. This invention, for the first time, utilizes a rationally composed mixture of collagenases to specifically strip coronary artery endothelial cells, minimizing non-specific damage to cardiomyocytes and stably inducing coronary artery injury to construct a zebrafish model of coronary artery injury, particularly coronary artery microcirculation injury. This model not only has a highly localized injury area and minimal impact on the myocardium, but also exhibits a low mortality rate. Furthermore, the zebrafish model of coronary artery injury constructed by this invention demonstrates significant regenerative potential, with its blood vessels exhibiting strong regenerative capacity. It also shows high sensitivity and responsiveness to drugs, making it potentially valuable in drug screening and mechanism research.
Owner:XUYIDA TECHNOLOGY IND DEVELOPMENT (XUZHOU) CO LTD +1